Press Releases

Press Releases

May 10, 2019
64% Q1 revenue growth and 650 bps gross margin improvement
May 06, 2019
Leading global neurology conference will feature 36 new Simoa-powered studies validating the use of Neurofilament light chain (Nf-L) as a potential diagnostic and prognostic biomarker for neurodegeneration   May 06, 2019 11:30 AM Eastern Daylight Time
March 28, 2019
Amol brings global pharmaceutical and diagnostic industry experience to management team to support rapid company growth and scaling 
January 10, 2019
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development
January 04, 2019
Company celebrates remarkable growth in 2018 fueled by new product launches, acceleration of ground-breaking publications and rapid adoption of digital biomarkers in neurology and oncology research